SRTS News and Press, Sensus Healthcare Inc. From 04/25/24

BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds investors that management will hold a conference call on...

BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursd...

Management will discuss its new “Fair Deal Agreement” for its SRT-100 Vision ™ IG-SRT in one-on-one meetings in Dana Point, California on March 18 th and 19 th BOCA RATON, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), ...

New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company’s booth generated a record-high number of sales leads and affirms very strong interest in a better economic choice ...

2024-02-25 14:02:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While people tend to avoid price hikes, certain stocks up 100% this year just might provide an exception to the rule. Basically, not even two months have passed by. If these securities are alre...

Sensus Healthcare, Inc. (NASDAQ: SRTS) is one of today's top gainers. The company's shares have moved 19.92% on the day to $4.85. Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial ...

2024-02-16 10:00:07 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...

2024-02-08 21:59:05 ET Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Conference Call February 08, 2024, 04:30 PM ET Company Participants Kim Golodetz - LHA, IR Joe Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - ...

2024-02-08 16:20:00 ET More on Sensus Healthcare Sensus Healthcare announces U.S. patent for SRT-100 Vision System Sensus Healthcare Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on Sensus Healthcare Historical earnings data for Sensus Healthca...

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision ™ (IG-SRT) to address dermatologist demand Conference c...